Compare Regeneron Pharmaceuticals Inc (REGN) vs Solaredge Technologies Inc (SEDG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Solaredge Technologies Inc — how do they compare? Regeneron Pharmaceuticals Inc trades at $740.02 (market cap $76.14B), while Solaredge Technologies Inc trades at $32.58 (market cap $2.00B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 38.1× Solaredge Technologies Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.51% dividend while Solaredge Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Regeneron Pharmaceuticals Inc for 107 Days and Solaredge Technologies Inc for 34 Days on average.
| REGN | SEDG | |
|---|---|---|
Market Cap | $76.14B | $2.00B |
Volume | 500,239 | 2,739,860 |
Sector | Health | Energy |
52-Week High | $852.03 | $78.51 |
52-Week Low | $557.73 | $28.47 |
Typical Hold Time | 107 Days | 34 Days |
Enterprise Value | $70.85B | $1.86B |
Dividend Yield | 0.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Regeneron Pharmaceuticals (REGN) trades at $742.12, up 0.46% on the day, with a bearish technical signal despite strong fundamentals. The stock shows robust profitability with a 27.86% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights a significant $8 billion immunology alliance expansion with Sanofi, providing substantial upfront and milestone payments.
The outlook is positive due to strong earnings momentum and strategic collaborations, but risks include competitive pressures in key drug markets and technical bearish indicators. Analyst consensus is bullish with a $849.84 price target, suggesting potential upside from current levels, though investors should monitor execution of new partnerships and pipeline developments.
SolarEdge Technologies (SEDG) trades at $33.16, down 2.59% with bearish technical signals and mixed fundamentals. The company shows revenue recovery to $1.18B in 2025 but continues posting significant losses with a -20.29% net margin. Recent news highlights legal investigations and AI data center initiatives, while analyst sentiment remains cautious with a $37.75 consensus target.
The outlook remains challenging with persistent profitability issues and legal overhangs, though the AI data center expansion offers long-term potential. Key risks include ongoing losses, high debt levels, and solar industry headwinds. The stock presents speculative appeal for investors betting on a turnaround, but requires careful risk assessment given the current financial strain.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →
